Accelerating the search for new treatments for neurodegenerative diseases
LifeArc and scientists in Italy develop a screening test that could help speed up the discovery of potential medicines to ALS.
LifeArc’s Head of Ventures, Clare Terlouw speaks with @FT Global Pharma Correspondent @hannahkuchler discussing RQ… https://t.co/fqrxEXr3Xf
KQ Labs data driven health accelerator announces its first exit, as Glamorous AI is acquired by X-Chem Inc
Programme delivered by the Francis Crick Institute and funded by LifeArc is proud to announce its first exit.
Investigational treatment may reduce need for a ventilator for hospitalised COVID-19 patients
An oral drug may reduce the need for oxygen therapy and speed recovery of hospitalised COVID-19 patients.…
Three new Trustees bring more skills and experience to LifeArc
A very warm welcome to three new Trustees who have joined our Board.
LifeArc scientist wins prestigious Industrial Fellowship
LifeArc scientist receives an industry fellowship from the Royal Commission for the Exhibition of 1851
A warm welcome to our 2021-2 industrial placement students
Welcoming students to our industrial placement scheme for 2021
Highlights of the year from our outgoing placement students
Students from our industrial placement scheme for 2020 review their year working in drug discovery at LifeArc
Industrialising academic-led gene therapies
Sven Kili, Chair of the Coordinating Committee overseeing the creation of the Gene Therapy Innovation Hubs, discusses how Gene Therapy Innovation Hubs will advance promising research into new treatments for patients.
Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases
Funding for pioneering research by University of Sheffield in collaboration with the Cell and Gene Therapy Catapult